Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Clinical Imbalances

Neurological

1

Immune and inflammation

1

Modifiable Lifestyle Factors

Exercise and movement

1

Laboratory Testing

Breath

1

Text Availability

Abstract

110

Full text

79

Free full text

56

Publication Types

Journal Article

111

Research Support, Non-U.S. Gov't

45

Randomized Controlled Trial

42

Review

26

Comparative Study

15

Meta-Analysis

12

Multicenter Study

12

Clinical Trial

9

Research Support, N.I.H., Extramural

8

Systematic Review

5

Observational Study

5

Clinical Trial, Phase III

3

Research Support, U.S. Gov't, P.H.S.

3

Case Reports

2

Clinical Trial, Phase II

1

Clinical Trial, Phase I

1

Historical Article

1

Clinical Trial, Phase IV

1

Scoping Review

1

Pragmatic Clinical Trial

1

Publication Year

From

To

Quick links

Individual year

2026

2

2025

4

2024

2

2023

3

2022

5

2021

6

2020

6

2019

5

2018

9

2017

9

2016

11

2015

6

2014

5

2013

11

2012

6

2011

3

2010

2

2009

2

2007

3

2006

1

2005

4

2004

5

2000

1

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for

""Adrenergic beta-2 Receptor Agonists""[mesh_terms]

111 Results

Searching titles within these results

Pharmacogenetics of beta2-agonist drugs in asthma.

D Robin Taylor

Clinical reviews in allergy & immunology 2007;31(2-3):247-58

Utility of inhaled β2-agonists in reducing serum potassium levels in adult patients with hyperkalemia: A scoping review.

Leonardo Arzayus-Patiño, Ashley Y Hinojosa-Angulo, Karen A Rodríguez-Angulo, Michelle A Sánchez-Caicedo, Vicente Benavides-Córdoba

PloS one 2026;21(2):e0342309

Current issues with beta2-adrenoceptor agonists: pharmacology and molecular and cellular mechanisms.

Gary P Anderson

Clinical reviews in allergy & immunology 2007;31(2-3):119-30

Muscle hypertrophic effect of inhaled beta -agonist is associated with augmented insulin-stimulated whole-body glucose disposal in young men.

Morten Hostrup, Jens Bangsbo, Vibeke Backer, Kasper Eibye, Johan Onslev, Thomas Baasch-Skytte, Søren Jessen

The Journal of physiology 2022;600(10):2345-2357

Unintentional oral beta agonist overdose: case report and review of the literature.

Ronit Marom, Dennis Scolnik, Dana Danino, Lea Koren, Ayelet Rimon, Miguel Marcelo Glatstein

American journal of therapeutics 2013;20(3):311-4

Anabolic and lipolytic actions of beta -agonists in humans and antidoping challenges.

Anders Krogh Lemminger, Søren Jessen, Glenn A Jacobson, Morten Hostrup

Drug testing and analysis 2021;12(5):597-609

Assay validation for vilanterol and its metabolites in human urine with application for doping control analysis.

Erik Soeren Halvard Hansen, Peter Daley-Yates, Morten Hostrup, Vibeke Backer, Martin Østergaard, Sandra Baldwin, Tina Panchal

Drug testing and analysis 2023;15(5):495-505

Urine concentrations of vilanterol and its metabolites, GSK932009 and GW630200, after inhalation of therapeutic and supratherapeutic doses.

Martin Østergaard, Søren Jessen, Erik Søren Halvard Hansen, Vibeke Backer, Tina Panchal, Sandra Baldwin, Peter Daley-Yates, Morten Hostrup

Drug testing and analysis 2023;15(5):516-528

Beta-adrenergic stimulation increases energy expenditure at rest, but not during submaximal exercise in active overweight men.

Vibeke Backer, Morten Hostrup, Jens Bangsbo, Søren Jessen, Michael Kreiberg, Anders Kalsen, Christian Narkowicz, Glenn Jacobson, Johan Onslev

European journal of applied physiology 2018;117(9):1907-1915

Beta-2 mimetics and magnesium: true or false friends?

Jean Durlach, Nicole Pagès, Pierre Bac, Michel Bara, Andrée Guiet-Bara

Magnesium research 2004;16(3):218-33

As-needed inhaled beta2-adrenoceptor agonists in moderate-to-severe asthma: current recommendations.

Donald W Cockcroft

Treatments in respiratory medicine 2005;4(3):169-74

Early control treatment with montelukast in preschool children with asthma: A randomized controlled trial.

Takao Fujisawa, Toshio Katsunuma, Tetsuro Kitamura, Chizu Habukawa, Norimasa Fukuda, Masanori Ikeda, Mizuho Nagao

Allergology international : official journal of the Japanese Society of Allergology 2018;67(1):72-78

Is it preferable to administer a bronchodilator once- or twice-daily when treating COPD?

Barbara Rinaldi, Mario Cazzola, Concetta Ambrosio, Maria Gabriella Matera

Respiratory medicine 2023;219():107439

Escalation and De-escalation of Therapy in COPD: Myths, Realities and Perspectives.

Mario Cazzola, Paola Rogliani, Maria Gabriella Matera

Drugs 2016;75(14):1575-85

The Association Between Short-Acting β-Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia.

Kerry Hancock, Ruth Murray, Sinthia Bosnic-Anticevich, David Price, Christine Jenkins, Anita Sharma, Victoria Carter, Rebecca Vella, Chantal Le Lievre, Eric Bateman, Bruce Willet, Deb Stewart, Josephine Samuel-King, Alexander Roussos, Kanchanamala Ranasinghe, John Pakos, Dominique Novic, Chi Ming Lau, Thao Le, Ata Kichkin, Kirsty Fletton, Joe Doan, Angelina Catanzariti, Fabio Botini, Maarten Beekman, Porsche Le Cheng, Florian Heraud

Advances in therapy 2024;41(3):1262-1283

Results: 1 – 15 / 111

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.